
Savaria Co. (TSE:SIS - Free Report) - Equities researchers at National Bank Financial lifted their Q3 2025 earnings per share (EPS) estimates for shares of Savaria in a report issued on Sunday, August 10th. National Bank Financial analyst Z. Evershed now expects that the company will earn $0.31 per share for the quarter, up from their prior forecast of $0.25. The consensus estimate for Savaria's current full-year earnings is $1.20 per share. National Bank Financial also issued estimates for Savaria's Q4 2025 earnings at $0.32 EPS and FY2026 earnings at $1.28 EPS.
Several other equities research analysts have also weighed in on the company. TD Securities increased their target price on Savaria from C$22.00 to C$24.00 and gave the stock a "buy" rating in a research report on Thursday, May 8th. National Bankshares increased their target price on Savaria from C$24.00 to C$26.00 and gave the stock an "outperform" rating in a research report on Monday. Six analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Savaria presently has a consensus rating of "Buy" and a consensus target price of C$24.17.
Get Our Latest Report on SIS
Savaria Stock Performance
Shares of SIS stock traded down C$0.34 on Tuesday, hitting C$20.95. 118,485 shares of the stock traded hands, compared to its average volume of 105,387. The company has a debt-to-equity ratio of 54.11, a current ratio of 1.97 and a quick ratio of 0.91. The company has a market capitalization of C$1.51 billion, a PE ratio of 32.78, a PEG ratio of 42.72 and a beta of 0.90. Savaria has a 1-year low of C$14.97 and a 1-year high of C$23.92. The company's fifty day moving average is C$19.69 and its 200 day moving average is C$18.38.
Savaria Company Profile
(
Get Free Report)
Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company's operating segments are the Accessibility, Adapted Vehicles, and Patient Handling, divisions.
Read More

Before you consider Savaria, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Savaria wasn't on the list.
While Savaria currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.